AI in biopharma only delivers value when data, analysis, and decisions are tightly connected
OmicsChart (now rebranded as Vedaly) is a patient-centric cancer data and analytics platform for translational cancer biologists and biopharma R&D teams. The platform enables translational and R&D teams to architect scalable data foundations, integrate complex biological and clinical data, and operationalize AI so it directly informs scientific and strategic decisions. OmicsChart joined the Milner Therapeutics Institute network at Cambridge University in 2024 and rebranded to Vedaly in November 2025 to reflect its expanded scope of services.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2023
Create a free account to see which investors have funded this company.
Create Free Account
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...
Cyera transforms the way organizations secure data in the cloud with Data Reality.
